The 3rd Workshop on
Recent Issues in Regulated Bioanalysis

April 16th– 17th, 2009, Montreal, Canada
Short Courses: April 15th, 2009
Grand Plaza Montreal Centre-Ville

Highlights | Speakers | Workshop Program

Short Courses | Sponsors | Previous Edition White Papers

CONTRIBUTING SPEAKERS
Regulatory Bodies

Dr. Brian P. Booth, Deputy Director, U.S. FDA
Louise Mawer, Senior GCP Inspector, U.K. MHRA
Eric Ormsby, Acting Manager, Health Canada TPD

Pharmas

Dr. Douglas M. Fast, Director, Bioanalytical Research Pharmacokinetics, Dynamics, and Metabolism, Pfizer
Dr. Patrick T. Vallano, Bioanalytical Laboratory, Mylan Pharmaceuticals
Dr. Rupinder Phull, Director PK/BE, Barr Laboratories
Michael Lindsay, Director Bioanalytical Laboratory, Apotex
Peter van Amsterdam, Head of Global Bioanalytics, Solvay Pharmaceuticals / European Bioanalysis Forum (EBF)

CROs

Dr. Mario L. Rocci, Jr, Executive Vice President, Prevalere Life Sciences
Dr. Stephen Lowes, Senior Vice President Scientific, Advion BioServices
Dr. Robert Masse Vice President, Bioanalytical Division, Anapharm - A PharmaNet Company
Dr. Fabio Garofolo, Vice President Bioanalytical Services, Algorithme Pharma

The 3rd Workshop on Recent Issues in Regulated Bioanalysis

The 3rd Workshop on
Recent Issues in Regulated Bioanalysis